Ebola Bundibugyo Vaccines in Development Four Months Before Outbreak
An Ebola outbreak in the Ituri province of the Democratic Republic of the Congo (DRC) was confirmed by the Africa Centers for Disease Control and Prevention (Africa CDC) on May 15, 2026. Through laboratory analysis, health officials confirmed that the outbreak is caused by the Bundibugyo ebola strain, for which there is no vaccine currently […]
Scientists Creating mRNA Biologics with Added Aluminum Adjuvant
Scientists at Boston Children’s Hospital in Massachusetts have developed an experimental mRNA biologic technology that they say produced longer-lasting immune responses in animal studies without the use of additional booster shots. The 2026 study was published in Nature Immunology.1 The research looked at a challenge in mRNA technology on how to make protection last longer […]
“Unjected” Dating App for Unvaccinated People Faces Backlash for Hosting Singles Meetups
A Denver, Colorado venue canceled an upcoming singles event called The Freedom Mixer for the unvaccinated community due to “safety concerns,” multiple news outlets have reported. The event, organized by Unjected, a dating app launched in 2021 and “built on creating health-conscious relationships with those who share like-minded values and the convictions to remain unvaccinated,” […]
U.S. Troops No Longer Required to Take Annual Flu Shot
U.S. Secretary of War Pete Hegseth announced on Apr. 21, 2026 that, effective immediately, military service members are no longer required to receive the annual flu vaccine. The update was shared in an Apr. 20 memorandum stating that the flu vaccine is now “voluntary for all active and reserve component service members, as well as […]
Pfizer, BioNTech End mRNA COVID-19 Biologic Trial Early
After failing to recruit enough eligible volunteers to generate enough data in the U.S. to meet U.S. Food and Drug Administration (FDA) post-marketing evidence requirements, Pfizer, Inc. and BioNTech SE have halted a large clinical trial of their updated mRNA COVID-19 biologic. The study targeted healthy adults 50 to 64 years of age but fell […]
Moderna’s mNEXSPIKE mRNA COVID-19 Shot Approved by European Commission
The European Commission (EC) has granted marketing authorization for Moderna’s mNEXSPIKE mRNA COVID-19 shot, allowing it to be marketed across the European Union (U.N.). The authorization follows a regulatory review and permits all 27 E.U. Member States, as well as Iceland, Liechtenstein and Norway, to consider the shot for use within their vaccination programs. It […]